EUCTR2004-002109-58-IT进行中（未招募）不适用
A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 efaproxiral , in Women with Brain Metastases from Breast Cancer
ALLOS0 个研究点目标入组 360 人开始时间: 2006年2月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases from Breast Cancer-C509 Breast, unspecifiedBreast, unspecifiedC509PER-077-04ALLOS THERAPEUTICS, INC.,
进行中（未招募）
不适用
A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases from Breast Cancer. - ENRICH studyBrain metastases from breast cancerMedDRA version: 4.0Level: 4Classification code 10027453EUCTR2004-002109-58-ESALLOS Therapeutics, Inc.360
进行中（未招募）
1 期
A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases from Breast Cancer - ENRICH studyBrain metastases from breast cancerMedDRA version: 4.0 Level: 4 Classification code 10027453EUCTR2004-002109-58-GBALLOS Therapeutics, Inc.360
进行中（未招募）
不适用
A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases from Breast Cancer - ENRICH studyBrain metastases from breast cancerMedDRA version: 4.0Level: 4Classification code 10027453EUCTR2004-002109-58-HUALLOS Therapeutics, Inc.360
进行中（未招募）
不适用
A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases from Breast Cancer - ENRICH studyBrain metastases from breast cancerMedDRA version: 4.0Level: 4Classification code 10027453EUCTR2004-002109-58-LTALLOS Therapeutics, Inc.360